Nanoviricides Inc (NNVC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 03-2011 | 12-2010 | 09-2010 | 06-2010 | 03-2010 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -5,220 | -2,673 | -1,098 | N/A | -4,081 |
| Depreciation Amortization | 158 | 105 | 51 | N/A | 43 |
| Accounts payable and accrued liabilities | -556 | -241 | -478 | N/A | 508 |
| Other Working Capital | -666 | -198 | -450 | N/A | 529 |
| Other Operating Activity | 2,617 | 559 | 526 | 0 | 1,269 |
| Operating Cash Flow | $-3,667 | $-2,448 | $-1,449 | $N/A | $-1,732 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -131 | -107 | -107 | N/A | -188 |
| Purchase Sale Intangibles | -40 | -18 | -18 | N/A | -135 |
| Other Investing Activity | -40 | -26 | -18 | 0 | -135 |
| Investing Cash Flow | $-171 | $-133 | $-125 | $N/A | $-323 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 50 | N/A | N/A | N/A | 1,881 |
| Common Stock Issued | N/A | N/A | N/A | N/A | 1,432 |
| Other Financing Activity | 4,595 | 4,620 | 2,295 | 0 | 0 |
| Financing Cash Flow | $4,645 | $4,620 | $2,295 | $N/A | $3,314 |
| Beginning Cash Position | 6,956 | 6,956 | 6,956 | N/A | 1,689 |
| End Cash Position | 7,763 | 8,995 | 7,678 | N/A | 2,948 |
| Net Cash Flow | $808 | $2,039 | $722 | $N/A | $1,259 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,667 | -2,448 | -1,449 | N/A | -1,732 |
| Capital Expenditure | -131 | -107 | -107 | N/A | -188 |
| Free Cash Flow | -3,798 | -2,555 | -1,555 | 0 | -1,920 |